LAS VEGAS, July 14 /PRNewswire-FirstCall/ -- Premier Platform Holding Company, Inc. (OTC Pink Sheets: PPFM) is pleased to announce that negotiations to acquire EverWell have progressed since the initial news discussed earlier this month. PPFM now plans to purchase 90% of the company, up from the proposed 45% mentioned in the press release of July 6.
PPFM is also currently negotiating to acquire 40% of AngioScan Biotech Inc., which has developed a revolutionary "early risk" screening methodology for breast imaging.
"I am very excited about joining Premier Platform as CEO," stated Loren Brink, chief executive officer of EverWell. "There are many synergies between our company and the AngioScan Biotech system," he concluded.
The EverWell product is an Online Health program for individuals, supported by a Health Coaching component, along with a wide range of high- quality, licensed, self-help and health-content programs.
Mr. Brink was previously the CEO of Health Fitness Corporation (BULLETIN BOARD: HFIT) from 1981 to 2000. He has spent his entire business career in the health care field.
Statements about the company's future expectations including future revenues and earnings, and all other statements in this news release other than historical facts are "forward-looking statements." Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results may differ materially from the company's plans if its assumptions prove to be incorrect, or for a variety of other reasons.
Premier Platform Holding Company Inc. is not a reporting company registered under the Securities Act of 1934. Shares of its stock trade under the symbol "PPFM."
Premier Platform Holding Company, Inc.CONTACT: Howard A. Scala, President, Wall Street Communications, Inc.,+1-800-338-9338
